Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Without swift unprecedented action, more than 2 million Americans could die.
Attendees will hear news about the second probable HIV cure, long-acting injectable meds and COVID-19.
Jill Cadman is a former patient advocate and educator living with HIV and Stage IV colon cancer.
This year’s theme is “Communities Make the Difference.”
International ‘dream team’ to use new technologies and prevention approaches to help those at highest risk.
People with HIV had low rates of complications similar to those of HIV-negative patients.
As an eligibility barrier cracks, a lung cancer patient gets a new lease on life.
European and U.S. guidelines recommend that all those with cirrhosis undergo biannual screening for liver cancer.
People living with HIV are also facing cancer as they age.
Could new cancer drugs restore immune responses against HIV?
Keytruda and Imfinzi showed response rates and safety profiles similar to those seen in HIV-negative people.
Nearly 21 million Americans could lose coverage. Meanwhile, the GOP won’t offer a health care replacement until after 2020.
Cancer organizations and the Food and Drug Administration want to broaden eligibility criteria for cancer clinical trials.
Study suggests current lung cancer screening guidelines may be inadequate for HIV-positive people.
Clinical trials often exclude key patient populations, including children and people living with HIV or hepatitis B or C.
People with HIV who have higher viral load and worse immune function appear to be at higher risk for hepatocellular carcinoma.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.